244 related articles for article (PubMed ID: 2025847)
41. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II.
Burgert EO; Nesbit ME; Garnsey LA; Gehan EA; Herrmann J; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P
J Clin Oncol; 1990 Sep; 8(9):1514-24. PubMed ID: 2099751
[TBL] [Abstract][Full Text] [Related]
42. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
[TBL] [Abstract][Full Text] [Related]
43. Extraskeletal Ewing's sarcoma.
Ahmad R; Mayol BR; Davis M; Rougraff BT
Cancer; 1999 Feb; 85(3):725-31. PubMed ID: 10091746
[TBL] [Abstract][Full Text] [Related]
44. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H;
J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150
[TBL] [Abstract][Full Text] [Related]
45. Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma.
Bacci G; Picci P; Mercuri M; Ferrari S; Longhi A; Cesari M; Rosito P; Mancini AF; Barbieri E; Baldini N
Acta Oncol; 1998; 37(7-8):671-6. PubMed ID: 10050985
[TBL] [Abstract][Full Text] [Related]
46. Ewing's sarcoma: a trial of adjuvant chemotherapy and sequential half-body irradiation.
Berry MP; Jenkin RD; Harwood AR; Cummings BJ; Quirt IC; Sonley MJ; Rider WD
Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):19-24. PubMed ID: 3943988
[TBL] [Abstract][Full Text] [Related]
47. Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials.
Schuck A; Ahrens S; Paulussen M; Kuhlen M; Könemann S; Rübe C; Winkelmann W; Kotz R; Dunst J; Willich N; Jürgens H
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):168-77. PubMed ID: 12504050
[TBL] [Abstract][Full Text] [Related]
48. Ewing's sarcoma: experience with 12 cases.
Zülfikar B; Gedikoğlu G
J Chemother; 1992 Feb; 4(1):50-5. PubMed ID: 1403071
[TBL] [Abstract][Full Text] [Related]
49. [Results of treatment of primary metastatic Ewing sarcoma. A retrospective analysis of 48 patients].
Wessalowski R; Jürgens H; Bodenstein H; Brandeis W; Gutjahr P; Havers W; Huckels-Klasen ML; Kotz R; Kühl J; Salzer-Kuntschik M
Klin Padiatr; 1988; 200(3):253-60. PubMed ID: 3062262
[TBL] [Abstract][Full Text] [Related]
50. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
51. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
La TH; Meyers PA; Wexler LH; Alektiar KM; Healey JH; Laquaglia MP; Boland PJ; Wolden SL
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):544-50. PubMed ID: 16198063
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study).
Oberlin O; Deley MC; Bui BN; Gentet JC; Philip T; Terrier P; Carrie C; Mechinaud F; Schmitt C; Babin-Boillettot A; Michon J;
Br J Cancer; 2001 Nov; 85(11):1646-54. PubMed ID: 11742482
[TBL] [Abstract][Full Text] [Related]
53. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
Krasin MJ; Davidoff AM; Rodriguez-Galindo C; Billups CA; Fuller CE; Neel MD; Merchant TE
Cancer; 2005 Jul; 104(2):367-73. PubMed ID: 15948159
[TBL] [Abstract][Full Text] [Related]
54. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party.
Craft AW; Cotterill SJ; Bullimore JA; Pearson D
Eur J Cancer; 1997 Jun; 33(7):1061-9. PubMed ID: 9376188
[TBL] [Abstract][Full Text] [Related]
55. [Therapy results of the British ET-1 study for Ewing's sarcoma].
Dunst J
Strahlenther Onkol; 1998 May; 174(5):289-90. PubMed ID: 9614962
[No Abstract] [Full Text] [Related]
56. Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG).
Shankar AG; Pinkerton CR; Atra A; Ashley S; Lewis I; Spooner D; Cannon S; Grimer R; Cotterill SJ; Craft AW
Eur J Cancer; 1999 Nov; 35(12):1698-704. PubMed ID: 10674016
[TBL] [Abstract][Full Text] [Related]
57. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
Nesbit ME; Gehan EA; Burgert EO; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P; Askin FB; Kissane JM
J Clin Oncol; 1990 Oct; 8(10):1664-74. PubMed ID: 2213103
[TBL] [Abstract][Full Text] [Related]
58. Management and results of localized Ewing's sarcoma.
Chan RC; Sutow WW; Lindberg RD; Samuels ML; Murray JA; Johnston DA
Cancer; 1979 Mar; 43(3):1001-6. PubMed ID: 106949
[TBL] [Abstract][Full Text] [Related]
59. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.
Oberlin O; Habrand JL; Zucker JM; Brunat-Mentigny M; Terrier-Lacombe MJ; Dubousset J; Gentet JC; Schmitt C; Ponvert D; Carrié C
J Clin Oncol; 1992 Sep; 10(9):1407-12. PubMed ID: 1517783
[TBL] [Abstract][Full Text] [Related]
60. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
